Movers and SHAKERS
Sit Down With CEO Justin Dye
Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its strategy to become a leading vertically integrated cannabis holding company with a portfolio consisting of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Sit Down With Justin Dye. Last week, we were able to sit down with Schwazze CEO Justin Dye and received his high level views of the Company. As one would expect, Mr. Dye remains very upbeat about the near and long-term prospects of the Company and its ability to build CPG brands. Colorado is just the beginning. Once a solid base is built, Schwazze will look to other states for growth, applying the lessons learned from not only Colorado but the grocery business to be successful.
Star Buds Acquisition. Mr. Dye continues to expect the remaining Star Buds location to be acquired by the end of the first quarter. Once completed, this will drive the growth engine, in our view. But we believe Star Buds is just the beginning. We continue to believe Schwazze will announce additional acquisitions in its drive to become the largest cannabis player in Colorado ...
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.